Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Optibrium Receives Further Investment From Kester Capital
Optibrium™, a developer of software for drug discovery, today announced it has secured further investment […]
3Z Closes $2 Million Funding for Preclinical Development of Novel ADHD and Insomnia Therapeutics Identified by 3Z´s Zebrafish Drug Discovery Platform
3Z, a Reykjavik based drug discovery company is pleased to announce the closure of a $2 million funding round […]
BIOTEM Implements New Industrial Unit Dedicated to Development and Production of Immunoassays
BIOTEM, a hybrid Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO) focusing on high […]
Memorial MRI & Diagnostic Installs United Imaging's Pioneering 75 Cm, Ultra-wide-bore uMR OMEGA™
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, and Memorial […]
Valneva and Pfizer Enter Into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today announced […]
Aidoc Raises $110M to Address the Increasing Challenges Facing Health Systems by Using Artificial Intelligence
Aidoc, the leading provider of healthcare AI solutions, announced today a $110 million Series D round investment, […]
DiA Imaging Analysis Partners with Intelerad Medical Systems to Empower Echocardiography Labs with AI
Intelerad Medical Systems™, a global leader in medical image management solutions, and DiA Imaging Analysis, a […]
Computer Tool Can Track Stroke Rehabilitation to Boost Recovery
A sensor-equipped computer program can accurately identify and count arm movements in people undergoing stroke […]
New AI Tool Is Better at Spotting Heart Failure Than Current Tests
A new artificial intelligence (AI) tool can help diagnose acute heart failure more accurately than […]
NICE Recommends Use of Hansa Biopharma's Idefirix® (Imlifidase) as Desensitization Treatment for Highly Sensitized Kidney Transplant Patients
Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), pioneer in enzyme technology for rare immunological conditions, today […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more